Concepedia

Xingping Dai

XD

Statistics

Publications

8

Citations

182

H-Index

8

Active since

2007

Affiliations

Central South University(Current)

Xiangya Hospital Central South University

Second Xiangya Hospital of Central South University

PharmacoGenetics (China)

Xingping Dai is an author at Central South University specializing in metabolic syndrome, diabetes, and medicine.

ORCID

Top concepts

Publications per year

2007–2021

8

Publications

8

IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population

Qiong Huang, Ji‐Ye Yin, Xingping Dai et al. · Acta Pharmacologica Sinica · 2010 · 65 citations · Full text

, , +8

RETRACTED ARTICLE: Downregulated lncRNA CRNDE contributes to the enhancement of nerve repair after traumatic brain injury in rats

Min Yi, Xingping Dai, Qiuxia Li et al. · Cell Cycle · 2019 · 29 citations · Full text

Changqin NO. 1 inhibits neuronal apoptosis via suppressing GAS5 expression in a traumatic brain injury mice model

Xingping Dai, Min Yi, Dongsheng Wang et al. · Biological Chemistry · 2019 · 23 citations

NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus

Feifeng Sheng, Xingping Dai, Jian Qu et al. · Clinical and Experimental Pharmacology and Physiology · 2011 · 21 citations

, , +14

The genetic polymorphisms of β3-adrenergic receptor (AR) Trp64Arg and β2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients

Wei Mo, Guang-Gan Zhang, Tianlun Yang et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2007 · 13 citations

1–5 of 8